3Suppliers
4Customers
3Debt Items
0Related Chains

Source-Backed Evidence Depth

CNBX Pharmaceuticals Inc. (CNBX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
4Distinct source URLs
6High confidence
0.792Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

CNBX Pharmaceuticals Inc. Suppliers

TickerNameConfidenceEvidence
3I-L-P 3I-L-P 92% On March 10th, 2026, the Company executed a non-convertible Promissory Note with 3i L.P., a Delaware Limited Partnership for the amount of $45,000.
INSTITUTIONAL-INVESTOR INSTITUTIONAL-INVESTOR 92% The Institutional Investor agreed to forbear until June 1, 2026 from taking any action against the Company with respect to unpaid amounts owed and to waive certain other defaults under the Note and o…
PURISYS PURISYS 90% Additionally, in view of our upcoming submission of a pre-IND meeting request with the FDA, the Company may enter a new agreement with Purisys, a supplier of GMP (Good Manufacturing Practice) grade A…

CNBX Pharmaceuticals Inc. Customers

TickerNameConfidenceEvidence
AMERICAN-MINING-COMPANY AMERICAN-MINING-COMPANY 62% to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms. Recent Sales of Unregiste…
CANNABICS-PHARMACEUTICAL-INC CANNABICS-PHARMACEUTICAL-INC 62% hare-based payments and the valuation allowance on deferred tax assets. Principles of Consolidation The consolidated financial statements include the accounts of Cannabics Pharmaceutical Inc. and its…
G-R-I-N-ULTRA-LTD G-R-I-N-ULTRA-LTD 62% hare-based payments and the valuation allowance on deferred tax assets. Principles of Consolidation The consolidated financial statements include the accounts of Cannabics Pharmaceutical Inc. and its…
THRUST-ENERGY-CORP THRUST-ENERGY-CORP 62% to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms. Recent Sales of Unregiste…

CNBX Pharmaceuticals Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CNBX-DEBT Debt stack $120,000 90% Market cache reports total debt of $120,000.
CNBX-DEBT-8735 Xbrl Convertible 90% xbrl convertible detail from xbrl 2026-02-28.
CNBX-DEBT-8734 Warrants outstanding: 675123 90% xbrl warrant detail from xbrl 2021-08-31.

CNBX Pharmaceuticals Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CNBX Pharmaceuticals Inc..

CNBX Pharmaceuticals Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for CNBX Pharmaceuticals Inc..

CNBX Pharmaceuticals Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
CNBX
Unlock CNBX Supply Chain Data
Verified relationships include:
3I-L-P3I-L-PSupplier92%
INSTITUTIONAL-INVESTORINSTITUTIONAL-INVESTORSupplier92%
AMERICAN-MINING-COMPANYAMERICAN-MINING-COMPANYCustomer62%
CANNABICS-PHARMACEUTICAL-INCCANNABICS-PHARMACEUTICAL-INCCustomer62%
+6 more relationships locked
Subscribe — View plans →